On the morning of January 3,Kexing Biopharm signed an international commercialization cooperation agreement onEribulin Mesylate Injection, securing exclusive commercialization licensing and supply of the product from Xiling Lab Co., Ltd. in 36
SHENZHEN, China, Jan. 5, 2024 /PRNewswire/ On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on